Optical imaging for early detection of cervical cancer: state of the art and perspectives
- PMID: 37564164
- PMCID: PMC10411916
- DOI: 10.1117/1.JBO.28.8.080902
Optical imaging for early detection of cervical cancer: state of the art and perspectives
Abstract
Significance: Cervical cancer is one of the major causes of death in females worldwide. HPV infection is the key cause of uncontrolled cell growth leading to cervical cancer. About 90% of cervical cancer is preventable because of the slow progression of the disease, giving a window of about 10 years for the precancerous lesion to be recognized and treated.
Aim: The present challenges for cervical cancer diagnosis are interobserver variation in clinicians' interpretation of visual inspection with acetic acid/visual inspection with Lugol's iodine, cost of cytology-based screening, and lack of skilled clinicians. The optical modalities can assist in qualitatively and quantitatively analyzing the tissue to differentiate between cancerous and surrounding normal tissues.
Approach: This work is on the recent advances in optical techniques for cervical cancer diagnosis, which promise to overcome the above-listed challenges faced by present screening techniques.
Results: The optical modalities provide substantial measurable information in addition to the conventional colposcopy and Pap smear test to clinically aid the diagnosis.
Conclusions: Recent optical modalities on fluorescence, multispectral imaging, polarization-sensitive imaging, microendoscopy, Raman spectroscopy, especially with the portable design and assisted by artificial intelligence, have a significant scope in the diagnosis of premalignant cervical cancer in future.
Keywords: Raman spectroscopy; cervical cancer diagnosis; fluorescence imaging; multimodal imaging; optical imaging; point-of-care; polarization-sensitive; white light imaging.
© 2023 The Authors.
Figures
References
-
- World Health Organization, World Fact Sheet, International Agency for Research on Cancer; (2020), https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-she... (accessed 4 August 2023).
-
- Ferlay J., et al. , Global and regional estimates of the incidence and mortality for 38 cancers: GLOBOCAN 2018, World Health Organization, International Agency for Research on Cancer, Lyon, France: (2018).
-
- World Health Organization, United Nations Population Fund, “Preparing for the introduction of HPV vaccines: policy and programme guidance for countries,” (2006).
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
